Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, 400076, India.
Centre for Research in Nanotechnology and Science, Indian Institute of Technology Bombay, Mumbai, 400076, India.
J Biomed Mater Res B Appl Biomater. 2018 Apr;106(3):1286-1298. doi: 10.1002/jbm.b.33941. Epub 2017 Jun 21.
We show that addition of nanozeolite (NZ) and vitamin E D-α-Tocopherol polyethylene glycol succinate (TPGS or T) considerably improves the performance of polyethersulfone (PES or P) hollow fiber membrane (HFM) for hemodialysis. Nanocomposite HFMs were manufactured using PES as a polymer, TPGS as an additive and NZ as a filler to give a composite membrane called PT-NZ. HFMs were spun by dry-wet spinning principle based on liquid-liquid phase separation. TPGS and NZ were successfully incorporated in HFMs, as confirmed by EDX elemental mapping. The resultant PT-NZ HFMs had improved hemocompatibility: lower percent hemolysis (0.28% in batch mode and 0.32% in continuous mode), lower platelet adhesion, higher coagulation time and lower protein adsorption (16.34 µg/cm ), compared with P, PT, and commercial (F60S) HFMs. The ultrafiltration coefficient of PT-NZ HFM-based module (274.59 mL/m /h/mmHg) was ∼1.5-times higher than that of F60S membranes (151.67 mL/m /h/mmHg), and the solute rejection of both the membranes was comparable. The toxin clearance performance of lab-scale PT-NZ HFM-based hemodialyzer with uremic toxin spiked goat blood was remarkably higher (five times) than that of F60S. Hence, the synthesized PT-NZ HFMs are a potentially attractive membrane material for hemodialysis application, particularly due to decreased treatment time and minimal side reactions. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1286-1298, 2018.
我们表明,添加纳米沸石(NZ)和维生素 E D-α-生育酚聚乙二醇琥珀酸酯(TPGS 或 T)可显著改善用于血液透析的聚醚砜(PES 或 P)中空纤维膜(HFM)的性能。使用 PES 作为聚合物、TPGS 作为添加剂和 NZ 作为填充剂制造纳米复合材料 HFMs,以赋予称为 PT-NZ 的复合膜。HFMs 通过基于液-液相分离的干湿纺丝原理纺制而成。通过 EDX 元素映射成功地将 TPGS 和 NZ 掺入 HFMs 中。与 P、PT 和商业(F60S)HFMs 相比,所得的 PT-NZ HFMs 具有改善的血液相容性:更低的溶血百分比(批处理模式下为 0.28%,连续模式下为 0.32%)、更低的血小板粘附、更高的凝血时间和更低的蛋白质吸附(16.34µg/cm )。基于 PT-NZ HFM 的模块的超滤系数(274.59 mL/m /h/mmHg)比 F60S 膜(151.67 mL/m /h/mmHg)高约 1.5 倍,并且两种膜的溶质截留率相当。用含尿毒症毒素的山羊血对实验室规模的基于 PT-NZ HFM 的血液透析器进行毒素清除性能测试,结果表明其性能明显更高(五倍)于 F60S。因此,合成的 PT-NZ HFMs 是一种用于血液透析应用的有吸引力的膜材料,特别是由于治疗时间缩短和最小的副作用。©2017 Wiley Periodicals, Inc. J 生物医学材料研究部分 B:应用生物材料,106B:1286-1298,2018 年。